Table 2.
Psoriasis treatment within the previous 12 months
| Type of treatmenta, n (%) | Placebo (n = 503) | Adalimumab (n = 966) |
|---|---|---|
| Topical | 380 (75.5) | 743 (76.9) |
| Phototherapy | 89 (17.7) | 176 (18.2) |
| Systemic non-biologic | 121 (24.1) | 232 (24.0) |
| Acitretin | 20 (4.0) | 33 (3.4) |
| Tazarotene | 17 (3.4) | 17 (1.8) |
| Cyclosporine | 18 (3.6) | 32 (3.3) |
| Methotrexate | 45 (8.9) | 94 (9.7) |
| Other | 31 (6.2) | 76 (7.9) |
| Systemic biologic | 63 (12.5) | 106 (11.0) |
| Alefacept | 23 (4.6) | 34 (3.5) |
| Efalizumab | 20 (4.0) | 30 (3.1) |
| Other | 24 (4.8) | 43 (4.5) |
| Laser | 3 (0.6) | 4 (0.4) |
aPatients may have received multiple previous treatments; therefore, the sums may exceed 100 %